A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer

MLA

Pax H.B. Willemse, et al. “A Randomized Comparison of Megestrol Acetate (MA) and Medroxyprogesterone Acetate (MPA) in Patients with Advanced Breast Cancer.” European Journal of Cancer and Clinical Oncology, vol. 26, Mar. 1990, pp. 337–43. EBSCOhost, https://doi.org/10.1016/0277-5379(90)90231-h.

APA

Pax H.B. Willemse, Henk Van Veelen, Dirk Sleijfer, Ton Tjabbes, & Els Van Der Ploeg. (1990). A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer. European Journal of Cancer and Clinical Oncology, 26, 337–343. https://doi.org/10.1016/0277-5379(90)90231-h

Chicago

Pax H.B. Willemse, Henk Van Veelen, Dirk Sleijfer, Ton Tjabbes, and Els Van Der Ploeg. 1990. “A Randomized Comparison of Megestrol Acetate (MA) and Medroxyprogesterone Acetate (MPA) in Patients with Advanced Breast Cancer.” European Journal of Cancer and Clinical Oncology 26 (March): 337–43. doi:10.1016/0277-5379(90)90231-h.